Prostock-studio – stock.adobe.com Ozempic mimics the GLP-1 hormone the body naturally produces after eating, suppressing ...

New weight loss drug target reduces appetite and burns calories without sickness - The discovery could lead to a new ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

They include MET-233i, an injectable amylin analog that is Metsera’s answer to the sector’s search for a once-monthly dosing ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Ozempic, Mounjaro, Wegovy, Victoza and Trulicity are part of a class of diabetes and obesity medications called GLP-1 drugs.

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists ... primarily because of ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...